Overview
Updated 14 Jul 2026
Theodore Hong, MD, is Director, Gastrointestinal Radiation Oncology Service at Massachusetts General Hospital. The public record shows 953 publications with 23,847 citations (h-index 70), centered on Pancreatic and Hepatic Oncology Research, Cancer Genomics and Diagnostics, Colorectal Cancer Treatments and Studies. It also documents an investigator role on 13 registered clinical trials, industry payments reported by 5 companies, 2 NIH-funded awards (2016–2025).
- Most recent indexed publication: 2026 · Clinical cancer research
- Top research focus: Pancreatic and Hepatic Oncology Research
- 13 registered trials on ClinicalTrials.gov
- Open Payments reporting from 5 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 26 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 243.
Clinical & industrytrials, payments and federal funding
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 13 registered studies on ClinicalTrials.gov. The most recent:
- ctDNA and Organ Preservation/Pathologic CR in Rectal Cancer
Sponsor: Massachusetts General Hospital
InvestigatorNot, yet, recruitingNCT05629442 - Nivolumab+Ipilimumab+RT in MSS mCRC
Sponsor: Massachusetts General Hospital
InvestigatorPhase 2UnknownNCT04575922 - Nivolumab + Ipilimumab + Radiation in MSS Pancreatic Cancer
Sponsor: Massachusetts General Hospital
InvestigatorPhase 2Active, not recruitingNCT04361162
Industry payments
Updated 14 Jul 2026
5 companies reported payments to CMS in program years 2021–2024. These are public disclosures, not judgments. The latest:
- IBA Proton Therapy, Inc.Program year20241 payment
- AstraZeneca Pharmaceuticals LPProgram year20231 payment
- Novocure Inc.Program year20221 payment
NIH funding
Updated 14 Jul 2026
2 NIH research awards on record, funded 2016–2025 per NIH RePORTER. The latest:
- Integrating patient-specific clinical and biological factors towards individualizing utilization of proton and photon radiation therapy.
Massachusetts General Hospital
FY2025$2,749,617P01CA261669 - Integrating patient-specific clinical and biological factors towards individualizing utilization of proton and photon radiation therapy.
Massachusetts General Hospital
FY2024$2,613,084P01CA261669
Congress activity
Updated 14 Jul 2026
250 congress contributions (2004–2026) across AACR, ASCO, ASTRO, SABCS per OpenAlex. The most recent:
- Alliance A022104/NRG-GI010, a randomized phase II/III trial testing the efficacy of triplet versus doublet chemotherapy regarding clinical complete response and disease-free survival in patients with locally advanced rectal cancer (LARC): The Janus Rectal Cancer trial.
ASCO Annual Meeting
ASCO2026Co-author - NRG-GI008: Colon adjuvant chemotherapy based on evaluation of residual disease (CIRCULATE-North America).
ASCO Annual Meeting
ASCO2026Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Reply to: Yttrium-90 Radioembolization Provides Durable Local Control and Definitive Radiation Therapy.
Journal of clinical oncology
2026 - Reply to: Quality of Chemoradiotherapy in Esophageal Adenocarcinoma Matters.
Journal of clinical oncology
2026
Most-cited worksby citation count (OpenAlex)
- 01Pancreatic Adenocarcinoma2,344 citations2014
- 02
- 03
- 04Treatment of Metastatic Colorectal Cancer: ASCO Guideline614 citations2022
- 05
Contact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
100 Blossom St, Cox Building, Boston, MA 02114
Network
Updated 14 Jul 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Editorial & leadership rolesjournal and society appointments
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hmfphysicians.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
- Chair
National Cancer Institute Rectal-Anal Cancer Task Force
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hmfphysicians.org ↗
Awards & honorshonors on the public record
- The One Hundred Honoree
Massachusetts General Hospital Cancer Center (annual recognition of leaders in the fight against cancer)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →giving.massgeneral.org ↗
Secondary affiliationsappointments beyond the home institution
- Incoming Vice Chair of Integration and Operations
Department of Radiation Oncology, Beth Israel Deaconess Medical Center (BIDMC), effective September 2026
2026provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hmfphysicians.org ↗ - Dana-Farber/Harvard Cancer Center
Co-Chair, Gastrointestinal Research Committee
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dfhcc.harvard.edu ↗
Media & interviewspress, podcasts and appearances
- Video interview
Mass General Cancer Center: discusses multidisciplinary GI cancer care planning and teamwork
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →massgeneral.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- Doximity
doximity.com/pub/theodore-hong-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/ted-hong-a82764111
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/profile/Theodore-Hong
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by otherswhere others cite or feature them
- Facebook
facebook.com/MGHCC/videos/the-importance-of-teamwork-and-a-multidisciplinary-approach-to-cancer-care-with-/200492497681559
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗ - YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗ - LinkedIn
LinkedIn: Ted Hong, MD - Vice Chair of Integration, Radiation Oncology (BIDMC/incoming)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Jonathan Rosand, MD
Massachusetts General Hospital
- 910
- publications
- 117
- h-index
- 1
- trial
Timothy Wilens, MD
Massachusetts General Hospital
- 658
- publications
- 101
- h-index
- 8
- trials
Michael Schwarzschild, MD
Massachusetts General Hospital
- 348
- publications
- 86
- h-index
- 3
- trials
Richard Penson, MD
Massachusetts General Hospital
- 394
- publications
- 68
- h-index
- 9
- trials